Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
Gynecologic Oncology Reports
|
August 1, 2025
Association of social vulnerability with access to treatment in ovarian cancer patients
Nikita Bastin, Marc Robinson, Amir Javid, et al.
Muscle & Nerve
|
June 1, 1987
Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers
G Rouleau, G Karpati, S Carpenter, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1993
The immunomodulatory effects of urine from patients with superficial bladder cancer receiving intravesical evans BCG therapy
A M Jackson, S Prescott, S J Hawkyard, et al.
International Journal of Oncology
|
May 12, 2011
Bacillus-calmette-guerin (bcg) organisms directly alter the growth of bladder-tumor cells
A Jackson, A Alexandroff, D Fleming, et al.
The Journal of Urology
|
August 1, 1993
The effect of recombinant cytokines on bladder cancer cells in vitro
S J Hawkyard, A M Jackson, S Prescott, et al.
Toxicology and Applied Pharmacology
|
April 1, 1997
Methyl tert-butyl ether causes alpha2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats
J S Prescott-Mathews, D C Wolf, B A Wong, et al.
British Journal of Urology
|
January 12, 1999
The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia
S Namasivayam, S Minhas, J Brooke, et al.
The Journal of Urology
|
November 1, 1992
Expression of adhesion molecules by bladder cancer cells: modulation by interferon-gamma and tumour necrosis factor-alpha
A M Jackson, A B Alexandrov, S Prescott, et al.
The Journal of Urology
|
June 1, 1992
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall
S Prescott, K James, T B Hargreave, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Immunopathological effects of intravesical BCG therapy
S Prescott, K James, T B Hargreave, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
Gynecologic Oncology Reports
|
August 1, 2025
Association of social vulnerability with access to treatment in ovarian cancer patients
Nikita Bastin, Marc Robinson, Amir Javid, et al.
Muscle & Nerve
|
June 1, 1987
Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers
G Rouleau, G Karpati, S Carpenter, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1993
The immunomodulatory effects of urine from patients with superficial bladder cancer receiving intravesical evans BCG therapy
A M Jackson, S Prescott, S J Hawkyard, et al.
International Journal of Oncology
|
May 12, 2011
Bacillus-calmette-guerin (bcg) organisms directly alter the growth of bladder-tumor cells
A Jackson, A Alexandroff, D Fleming, et al.
The Journal of Urology
|
August 1, 1993
The effect of recombinant cytokines on bladder cancer cells in vitro
S J Hawkyard, A M Jackson, S Prescott, et al.
Toxicology and Applied Pharmacology
|
April 1, 1997
Methyl tert-butyl ether causes alpha2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats
J S Prescott-Mathews, D C Wolf, B A Wong, et al.
British Journal of Urology
|
January 12, 1999
The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia
S Namasivayam, S Minhas, J Brooke, et al.
The Journal of Urology
|
November 1, 1992
Expression of adhesion molecules by bladder cancer cells: modulation by interferon-gamma and tumour necrosis factor-alpha
A M Jackson, A B Alexandrov, S Prescott, et al.
The Journal of Urology
|
June 1, 1992
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall
S Prescott, K James, T B Hargreave, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Immunopathological effects of intravesical BCG therapy
S Prescott, K James, T B Hargreave, et al.
Page
of 11